Presentation is loading. Please wait.

Presentation is loading. Please wait.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

Similar presentations


Presentation on theme: "SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson."— Presentation transcript:

1 SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson & Johnson Medical Devices & Diagnostics Medical Device Quality Enhancement An Industry Perspective

2 SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 2 Goal To improve product safety and quality, at lower total quality cost Engagement: How can Industry and FDA interact to identify way to focus on Quality Medical Device Quality Enhancement An Industry Perspective

3 SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 3 Medical Device Quality Enhancement: An Industry Perspective Clear priorities, aligned goals and objectives – Shifting the focus to quality from compliance – Evolve regulatory models to promote device quality and aligning industry and FDA to Focus on Quality – Achieve a preventative model with agreed Risk-Benefit framework – Improve our ability to measure quality and early indicators – Improve education and awareness within industry, – Clarify and communicate the Case for Quality – Identification and validation of Quality practices

4 SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 4 Medical Device Quality Enhancement: An Industry Perspective FDA and Industry engagement – Coalition for Enhancing medical device quality Transparency Engagement – Work streams Risk-benefit decision making Quality benchmarking, CTQ & root cause National and Local forum planning

5 SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 5 Leadership from FDA and Medical Device companies Strong foundation for productive relationships Dialogue between FDA and Medical Device companies Focus on Quality Medical Device Quality Enhancement An Industry Perspective

6 SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 6 Medical Device Quality Enhancement An Industry Perspective Thank you


Download ppt "SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson."

Similar presentations


Ads by Google